Developer docs
API playgroundTry for free, no card

Search company profiles

Biopuremax

Full company profile

uuid000oqep

Namestring
Biopuremax
Legal namestring
Biopuremax
Websiteurl
biopuremax.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Biopuremax is a privately held Israeli company, headquartered in Herzliya, that designs, supplies, and commissions standardized pharmaceutical water purification systems for the pharmaceutical and biotech industries. The company produces Purified Water (PW) and Water for Injection (WFI) systems using a chemical-free, media-free architecture that the company claims delivers up to 30% feed water savings versus traditional pretreatment. Founded with over 20 years of operating history in biopharmaceutical water systems, Biopuremax serves enterprise customers including Teva, Kamada, Pluristem, Taro Pharmaceutical, Omrix, VBL, TECPAR (Brazil), Theraskin (Brazil), and Accord (UK), with geographic reach spanning Israel, Brazil, Germany, the UK, the Netherlands, Turkey, and Canada.

The company's technical core is four proprietary, trademarked technologies: ESR (Electrolytic Scale Reduction), which precipitates scale-forming ions via a metallic reaction chamber with a central electrode; HOD (Hydro Optical De-Chlorination), a UV-based process that reduces free chlorine and disinfects water; CBR (Continuous Bioburden Reduction), which combines ESR-generated chlorine with HOD UV for ongoing bacterial control; and HWS (Hot Water Sanitization) at 80–90°C. These pretreatment modules feed into RO, CEDI, and Ultra Filtration systems to produce PW and WFI compliant with USP, European Pharmacopeia, and ISO 22519, with the company's ESR and HOD technologies explicitly codified in ISO 22519 (June 2019) and recognized in the ISPE Baseline Good Practice Guide. Capacity range is 0.5 m3/hr to 9.5 m3/hr, and systems are delivered with full Factory Acceptance Testing, SAT/Commissioning, and validation packages.

Biopuremax operates a direct enterprise sales model with no disclosed channel partners, supported by trade show presence (FCE Brazil, PDA Europe) and digital marketing via LinkedIn, YouTube, and webinars. Revenue is generated through three streams: one-time system sales, professional services for installation and commissioning, and after-sale services (filter and UV lamp replacement). The company is privately held with no disclosed funding rounds, parent company, or acquisition activity, and in July 2025 announced a strategic partnership with Insatech (Denmark) to broaden its equipment, instrumentation, and automation capabilities for the pharmaceutical and biotech end markets.

Short descriptiontext

Biopuremax is a privately held Israeli company that designs, supplies, and commissions chemical-free, media-free pharmaceutical water purification systems (PW and WFI) for enterprise pharmaceutical and biotech customers, using proprietary ESR, HOD, CBR, and HWS technologies compliant with USP, EP, and ISO 22519.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHerzliya, Israel
HQ citystring
Herzliya
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical water systems, water for injection, purified water treatment, biopharmaceutical equipment, RO pretreatment systems
Industry3 codes
PRIMARYIMAEABAN
Water Treatment & Process Specialty Chemicals
SECONDARYIMAEAJAC
Industrial Wastewater Treatment Chemicals
SECONDARYIMAEAJAE
Cooling Water Treatment Chemicals
NAICS code1 code
  • Other Basic Inorganic Chemical Manufacturing325180
SIC code1 code
  • Miscellaneous Chemical Products2890
Product category
Pharmaceutical Water Purification Systems
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Water Purification Systems
TypeOne Time License
Description

Sale of complete pharmaceutical water treatment systems including pretreatment, PW production, WFI systems, storage and distribution. Systems are custom-designed per client capacity needs (ranging from 0.5 m3/hr to 9.5 m3/hr). Includes FAT (Factory Acceptance Test), fabrication, programming, and design approval process.

biopuremax.com
2Installation and Commissioning Services
TypeProfessional Services
Description

Full installation, commissioning, and SAT services for Biopuremax systems. Complete validation package available for regulatory compliance.

biopuremax.com
3After-Sale Services
TypeProfessional Services
Description

Replacement of filters and UV lamps as ongoing maintenance. Scale precipitated in ESR automatically removed by cleaning cycle. After sales support and service.

biopuremax.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1ESR™ (Electrolytic Scale Reduction)
Description

Electrolytic technology for scale reduction in water treatment systems

biopuremax.com
+3 more records
Core offering1 text field

Biopuremax designs, manufactures, and installs standardized chemical-free, media-free pharmaceutical water purification systems for the pharma and biotech industries. The company offers complete Pretreatment, Purified Water (PW), and Water for Injection (WFI) systems based on its proprietary ESR™ (Electrolytic Scale Reduction) and HOD™ (Hydro Optical De-Chlorination) technologies combined with RO, CEDI, and UF processes, including installation, commissioning, validation, and after-sale services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Up to 30% savings on feed water compared to traditional pharmaceutical water treatment systems
+3 more records
Product overview1 text field

Biopuremax is a pharmaceutical water purification company offering a standardized package system for chemical-free, media-free water treatment. The core product portfolio centers on ESR™ (Electrolytic Scale Reduction), HOD™ (Hydro Optical De-Chlorination), and CBR™ (Continuous Bioburden Reduction) technologies combined with Hot Water Sanitization (HWS). These pretreatment technologies feed into RO (Reverse Osmosis), CEDI (Continuous Electro De-Ionization), and UF (Ultra Filtration) systems to produce Purified Water (PW) and Water for Injection (WFI) compliant with USP, EP, and ISO 22519 standards. The company provides complete A-to-Z systems including design, fabrication, installation, commissioning, validation, and after-sales services for pharmaceutical and biotech industries worldwide.

Product and service10 records
1Biopuremax Pretreatment System
CategoryPretreatment System
Description

Standardized pharmaceutical water pretreatment package providing chemical-free and media-free RO feed water for pharmaceutical and biotech manufacturers. Combines ESR™ and HOD™ technologies in a compact skid design with small footprint and low floor loading, eliminating softeners, carbon filters, and regeneration chemicals.

2PW (Purified Water) System
CategoryPurified Water Production
Description

Pharmaceutical purified water production system meeting USP standards. Uses Biopuremax pretreatment combined with RO and CEDI to deliver consistent, low-bacteria purified water suitable for pharmaceutical manufacturing.

3WFI (Water for Injection) System
CategoryWater for Injection Production
Description

Water for Injection production system using non-distillation membrane technologies (RO + CEDI + UF) compliant with European Pharmacopeia and US Pharmacopeia standards. Provides zero total bacteria count per ml with high reliability.

4Single Pass RO + CEDI + UF WFI System
CategoryWFI System Configuration
Description

Standard WFI system design using single pass RO membrane, CDI, and Ultra Filtration for water for injection production. Includes multimedia filter, ESR™, HOD™ UV, hot water sanitizable RO, CO2 degasser, and hot water sanitizable CEDI.

5Double Pass RO + CEDI WFI System
CategoryWFI System Configuration
Description

WFI system design using double pass RO membrane with CEDI for water for injection production. Features hot water sanitization, CO2 degasser, and dual-stage purification.

6Demonstration Unit
CategoryDemonstration Equipment
Description

Portable demonstration skid for placement in customer factories to showcase RO pretreatment with ESR™-HOD™ technology. Produces 100-250 L/hr with no need for softeners or chemicals, used as a sales tool and proof-of-concept.

7ESR™ (Electrolytic Scale Reduction) Technology
CategoryCore Technology Component
Description

Electrolytic scale reduction technology sold as part of integrated water treatment systems, precipitating scale-forming ions (calcium, magnesium, silica, iron, manganese) through high pH near the cathode, automatically removed by cleaning cycle. Generates free chlorine from naturally occurring chloride for bacterial reduction.

8HOD™ (Hydro Optical De-Chlorination) Technology
CategoryCore Technology Component
Description

UV-based dechlorination technology sold as part of integrated water treatment systems, decomposing free chlorine, chloramines, ozone, and chlorine dioxide from feed water while providing disinfection as a byproduct of the dechlorination process.

9CBR™ (Continuous Bioburden Reduction) Technology
10HWS (Hot Water Sanitization) Technology
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Insatech
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-07-14
Description

Partnership with Insatech, a leading Danish equipment, instrumentation and automation company. Partnership aligns with vision to deliver technology driven PW/WFI systems, free from bacteria, chemicals, and media for pharmaceutical and biotech industries. Insatech provides equipment, instrumentation and automation expertise to complement Biopuremax's water purification technology.

biopuremax.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Kurita Water Industries
TypeBroad incumbent
Description

Japanese-headquartered industrial water treatment and specialty chemicals company serving semiconductor, power, and pharmaceutical customers. Comparable in industrial water-purification technology, particularly membrane and ion-exchange based systems.

TypeDirect peer
Description

Japanese water and process-treatment specialist with dedicated pharmaceutical water systems (PW, WFI, pure steam) using membrane and ion-exchange technologies. Comparable niche player focused on pharma/biotech water.

TypeRegional player
Description

Processing and packaging equipment supplier to the pharma industry that also offers water treatment system solutions for pharmaceutical customers. Adjacent overlap with Biopuremax in pharma facility buildouts and project lifecycle.

TypeDirect peer
Description

European-headquartered water-treatment group with pharmaceutical-grade water (PW/WFI) systems and service offerings. Comparable to Biopuremax in pharma water treatment focus and European go-to-market.

5Christ Water Technology / Aqua Solutions
TypeDirect peer
Description

Pharmaceutical and high-purity water systems integrator (formerly Christ Water Technology) producing PW and WFI systems for drug manufacturers. Direct comparable as a specialist pharma water systems integrator.

TypeDirect peer
Description

Specialist in water treatment for pharmaceutical, medical, and laboratory applications, with PW, WFI and dialysis water systems. Directly comparable niche specialist competing for the same enterprise pharma clients.

7SUEZ Water Technologies & Solutions
TypeBroad incumbent
Description

Global water services provider with a strong pharma/biotech water systems portfolio including PW, WFI, and process water solutions. Directly comparable in target customer (pharma manufacturers) and overlapping technology stack.

TypeDirect peer
Description

Industrial water treatment and membrane filtration specialist offering RO, UF and NF systems for pharmaceutical-grade water. Comparable to Biopuremax in core membrane technology for PW/WFI production, with broader industrial reach.

9Veolia Water Technologies (now Veolia)
TypeBroad incumbent
Description

Global water-treatment major with a dedicated pharma/life-sciences portfolio producing PW, WFI, pure steam and distribution systems. Comparable to Biopuremax in target end-market, but broader scope and significantly larger scale.

TypeBroad incumbent
Description

Global specialty chemicals/services leader with pharmaceutical water treatment and purification solutions serving drug manufacturers. Competes with Biopuremax on enterprise pharma water accounts from a much broader portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers18 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biopuremax

Pharmaceutical Water Purification Systemsbiopuremax.com

Biopuremax is a privately held Israeli company that designs, supplies, and commissions chemical-free, media-free pharmaceutical water purification systems (PW and WFI) for enterprise pharmaceutical and biotech customers, using proprietary ESR, HOD, CBR, and HWS technologies compliant with USP, EP, and ISO 22519.

What Biopuremax does

Biopuremax is a privately held Israeli company, headquartered in Herzliya, that designs, supplies, and commissions standardized pharmaceutical water purification systems for the pharmaceutical and biotech industries. The company produces Purified Water (PW) and Water for Injection (WFI) systems using a chemical-free, media-free architecture that the company claims delivers up to 30% feed water savings versus traditional pretreatment. Founded with over 20 years of operating history in biopharmaceutical water systems, Biopuremax serves enterprise customers including Teva, Kamada, Pluristem, Taro Pharmaceutical, Omrix, VBL, TECPAR (Brazil), Theraskin (Brazil), and Accord (UK), with geographic reach spanning Israel, Brazil, Germany, the UK, the Netherlands, Turkey, and Canada.

The company's technical core is four proprietary, trademarked technologies: ESR (Electrolytic Scale Reduction), which precipitates scale-forming ions via a metallic reaction chamber with a central electrode; HOD (Hydro Optical De-Chlorination), a UV-based process that reduces free chlorine and disinfects water; CBR (Continuous Bioburden Reduction), which combines ESR-generated chlorine with HOD UV for ongoing bacterial control; and HWS (Hot Water Sanitization) at 80–90°C. These pretreatment modules feed into RO, CEDI, and Ultra Filtration systems to produce PW and WFI compliant with USP, European Pharmacopeia, and ISO 22519, with the company's ESR and HOD technologies explicitly codified in ISO 22519 (June 2019) and recognized in the ISPE Baseline Good Practice Guide. Capacity range is 0.5 m3/hr to 9.5 m3/hr, and systems are delivered with full Factory Acceptance Testing, SAT/Commissioning, and validation packages.

Biopuremax operates a direct enterprise sales model with no disclosed channel partners, supported by trade show presence (FCE Brazil, PDA Europe) and digital marketing via LinkedIn, YouTube, and webinars. Revenue is generated through three streams: one-time system sales, professional services for installation and commissioning, and after-sale services (filter and UV lamp replacement). The company is privately held with no disclosed funding rounds, parent company, or acquisition activity, and in July 2025 announced a strategic partnership with Insatech (Denmark) to broaden its equipment, instrumentation, and automation capabilities for the pharmaceutical and biotech end markets.

Biopuremax firmographics

Firmographics
Name
Biopuremax
Legal name
Biopuremax
Website
https://biopuremax.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Biopuremax is a privately held Israeli company that designs, supplies, and commissions chemical-free, media-free pharmaceutical water purification systems (PW and WFI) for enterprise pharmaceutical and biotech customers, using proprietary ESR, HOD, CBR, and HWS technologies compliant with USP, EP, and ISO 22519.
Ownership category
akta.pro rank

Biopuremax industry classification

Industry
Product category
Pharmaceutical Water Purification Systems
NAICS
Other Basic Inorganic Chemical Manufacturing (325180)
SIC
Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYIMAEABAN
Water Treatment & Process Specialty Chemicals
SECONDARYIMAEAJAC
Industrial Wastewater Treatment Chemicals
SECONDARYIMAEAJAE
Cooling Water Treatment Chemicals

Keywords

  • Pharmaceutical water systems
  • Water for injection
  • Purified water treatment
  • Biopharmaceutical equipment
  • RO pretreatment systems

Where Biopuremax is headquartered

Location

Headquarters

HQ city
Herzliya
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

Biopuremax business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Water Purification Systems: Sale of complete pharmaceutical water treatment systems including pretreatment, PW production, WFI systems, storage and distribution. Systems are custom-designed per client capacity needs (ranging from 0.5 m3/hr to 9.5 m3/hr). Includes FAT (Factory Acceptance Test), fabrication, programming, and design approval process.
  2. Installation and Commissioning Services: Full installation, commissioning, and SAT services for Biopuremax systems. Complete validation package available for regulatory compliance.
  3. After-Sale Services: Replacement of filters and UV lamps as ongoing maintenance. Scale precipitated in ESR automatically removed by cleaning cycle. After sales support and service.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Biopuremax product offering

Product offering

Core offering

Biopuremax designs, manufactures, and installs standardized chemical-free, media-free pharmaceutical water purification systems for the pharma and biotech industries. The company offers complete Pretreatment, Purified Water (PW), and Water for Injection (WFI) systems based on its proprietary ESR™ (Electrolytic Scale Reduction) and HOD™ (Hydro Optical De-Chlorination) technologies combined with RO, CEDI, and UF processes, including installation, commissioning, validation, and after-sale services.

Product overview

Biopuremax is a pharmaceutical water purification company offering a standardized package system for chemical-free, media-free water treatment. The core product portfolio centers on ESR™ (Electrolytic Scale Reduction), HOD™ (Hydro Optical De-Chlorination), and CBR™ (Continuous Bioburden Reduction) technologies combined with Hot Water Sanitization (HWS). These pretreatment technologies feed into RO (Reverse Osmosis), CEDI (Continuous Electro De-Ionization), and UF (Ultra Filtration) systems to produce Purified Water (PW) and Water for Injection (WFI) compliant with USP, EP, and ISO 22519 standards. The company provides complete A-to-Z systems including design, fabrication, installation, commissioning, validation, and after-sales services for pharmaceutical and biotech industries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • ESR™ (Electrolytic Scale Reduction): Electrolytic technology for scale reduction in water treatment systems
  • HOD™ (Hydro Optical De-Chlorination)
  • CBR™ (Continuous Bioburden Reduction)
  • HWS (Hot Water Sanitization)

Products and services

  • Biopuremax Pretreatment System Standardized pharmaceutical water pretreatment package providing chemical-free and media-free RO feed water for pharmaceutical and biotech manufacturers. Combines ESR™ and HOD™ technologies in a compact skid design with small footprint and low floor loading, eliminating softeners, carbon filters, and regeneration chemicals.
  • PW (Purified Water) System Pharmaceutical purified water production system meeting USP standards. Uses Biopuremax pretreatment combined with RO and CEDI to deliver consistent, low-bacteria purified water suitable for pharmaceutical manufacturing.
  • WFI (Water for Injection) System Water for Injection production system using non-distillation membrane technologies (RO + CEDI + UF) compliant with European Pharmacopeia and US Pharmacopeia standards. Provides zero total bacteria count per ml with high reliability.
  • Single Pass RO + CEDI + UF WFI System Standard WFI system design using single pass RO membrane, CDI, and Ultra Filtration for water for injection production. Includes multimedia filter, ESR™, HOD™ UV, hot water sanitizable RO, CO2 degasser, and hot water sanitizable CEDI.
  • Double Pass RO + CEDI WFI System WFI system design using double pass RO membrane with CEDI for water for injection production. Features hot water sanitization, CO2 degasser, and dual-stage purification.
  • Demonstration Unit Portable demonstration skid for placement in customer factories to showcase RO pretreatment with ESR™-HOD™ technology. Produces 100-250 L/hr with no need for softeners or chemicals, used as a sales tool and proof-of-concept.
  • ESR™ (Electrolytic Scale Reduction) Technology Electrolytic scale reduction technology sold as part of integrated water treatment systems, precipitating scale-forming ions (calcium, magnesium, silica, iron, manganese) through high pH near the cathode, automatically removed by cleaning cycle. Generates free chlorine from naturally occurring chloride for bacterial reduction.
  • HOD™ (Hydro Optical De-Chlorination) Technology UV-based dechlorination technology sold as part of integrated water treatment systems, decomposing free chlorine, chloramines, ozone, and chlorine dioxide from feed water while providing disinfection as a byproduct of the dechlorination process.
  • CBR™ (Continuous Bioburden Reduction) Technology
  • HWS (Hot Water Sanitization) Technology

Quantifiable outcome

  • Up to 30% savings on feed water compared to traditional pharmaceutical water treatment systems
  • +3 more outcomes

Companies that use Biopuremax

Customer profile

Named customers18 records

Segments2 records

Ideal customer profiles1 record

Biopuremax technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Biopuremax partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • InsatechcoreTechnology or Integration · 14 July 2025Partnership with Insatech, a leading Danish equipment, instrumentation and automation company. Partnership aligns with vision to deliver technology driven PW/WFI systems, free from bacteria, chemicals, and media for pharmaceutical and biotech industries. Insatech provides equipment, instrumentation and automation expertise to complement Biopuremax's water purification technology.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Biopuremax competitors and assessment

Company assessment

Broad incumbents

  • Kurita Water Industries: Japanese-headquartered industrial water treatment and specialty chemicals company serving semiconductor, power, and pharmaceutical customers. Comparable in industrial water-purification technology, particularly membrane and ion-exchange based systems.
  • SUEZ Water Technologies & Solutions: Global water services provider with a strong pharma/biotech water systems portfolio including PW, WFI, and process water solutions. Directly comparable in target customer (pharma manufacturers) and overlapping technology stack.
  • Veolia Water Technologies (now Veolia): Global water-treatment major with a dedicated pharma/life-sciences portfolio producing PW, WFI, pure steam and distribution systems. Comparable to Biopuremax in target end-market, but broader scope and significantly larger scale.
  • Ecolab Life Sciences (including previous Purolite and Nalco Water assets): Global specialty chemicals/services leader with pharmaceutical water treatment and purification solutions serving drug manufacturers. Competes with Biopuremax on enterprise pharma water accounts from a much broader portfolio.

Direct peers

  • Organo Corporation: Japanese water and process-treatment specialist with dedicated pharmaceutical water systems (PW, WFI, pure steam) using membrane and ion-exchange technologies. Comparable niche player focused on pharma/biotech water.
  • BWT (Best Water Technology): European-headquartered water-treatment group with pharmaceutical-grade water (PW/WFI) systems and service offerings. Comparable to Biopuremax in pharma water treatment focus and European go-to-market.
  • Christ Water Technology / Aqua Solutions: Pharmaceutical and high-purity water systems integrator (formerly Christ Water Technology) producing PW and WFI systems for drug manufacturers. Direct comparable as a specialist pharma water systems integrator.
  • Mar Cor Purification (Cantel Medical / Ecolab subsidiary): Specialist in water treatment for pharmaceutical, medical, and laboratory applications, with PW, WFI and dialysis water systems. Directly comparable niche specialist competing for the same enterprise pharma clients.
  • Pentair (X-Flow membrane business): Industrial water treatment and membrane filtration specialist offering RO, UF and NF systems for pharmaceutical-grade water. Comparable to Biopuremax in core membrane technology for PW/WFI production, with broader industrial reach.

Regional players

  • Syntegon (formerly Bosch Packaging Technology): Processing and packaging equipment supplier to the pharma industry that also offers water treatment system solutions for pharmaceutical customers. Adjacent overlap with Biopuremax in pharma facility buildouts and project lifecycle.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Biopuremax social profiles

Digital presence

Biopuremax compliance and trust

Trust signal

Compliance4 records

Biopuremax financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biopuremax leadership team

Management profile

Number of profiles

Profiles1 record

Biopuremax funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biopuremax M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biopuremax

What does Biopuremax do?

Biopuremax designs, manufactures, and installs standardized chemical-free, media-free pharmaceutical water purification systems for the pharma and biotech industries. The company offers complete Pretreatment, Purified Water (PW), and Water for Injection (WFI) systems based on its proprietary ESR™ (Electrolytic Scale Reduction) and HOD™ (Hydro Optical De-Chlorination) technologies combined with RO, CEDI, and UF processes, including installation, commissioning, validation, and after-sale services.

Is Biopuremax a public or private company?

Biopuremax is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Biopuremax founded?

Biopuremax was founded in 2015. It employs 11 to 50 people.

Where is Biopuremax based?

Biopuremax is headquartered in Herzliya, Israel, in the Middle East region.

How does Biopuremax make money?

Three revenue lines are on record. Water Purification Systems are the primary driver. The others are installation and Commissioning Services and after-Sale Services.

Who are Biopuremax's main competitors?

Broad incumbents on record are Kurita Water Industries, SUEZ Water Technologies & Solutions, Veolia Water Technologies (now Veolia) and Ecolab Life Sciences (including previous Purolite and Nalco Water assets). Direct peers are Organo Corporation, BWT (Best Water Technology), Christ Water Technology / Aqua Solutions, Mar Cor Purification (Cantel Medical / Ecolab subsidiary) and Pentair (X-Flow membrane business). Syntegon (formerly Bosch Packaging Technology) is listed as a regional player.

Does Biopuremax have an API?

No public API is recorded for Biopuremax.

What industry is Biopuremax in?

Biopuremax's product category is Pharmaceutical Water Purification Systems. Its primary akta.pro industry code is IMAEABAN, Water Treatment & Process Specialty Chemicals, with a secondary code of IMAEAJAC, Industrial Wastewater Treatment Chemicals. Its NAICS code is 325180 and its SIC code is 2890.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales